Zevra Therapeutics (ZVRA) Shares Issued (2016 - 2025)
Historic Shares Issued for Zevra Therapeutics (ZVRA) over the last 8 years, with Q3 2025 value amounting to $3.0 million.
- Zevra Therapeutics' Shares Issued fell 9525.01% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year decrease of 9153.87%. This contributed to the annual value of $64.5 million for FY2024, which is 95660.01% up from last year.
- Latest data reveals that Zevra Therapeutics reported Shares Issued of $3.0 million as of Q3 2025, which was down 9525.01% from $968000.0 recorded in Q2 2025.
- Zevra Therapeutics' Shares Issued's 5-year high stood at $63.4 million during Q3 2024, with a 5-year trough of -$2.3 million in Q3 2021.
- Its 5-year average for Shares Issued is $7.7 million, with a median of $968000.0 in 2025.
- Examining YoY changes over the last 5 years, Zevra Therapeutics' Shares Issued showed a top increase of 11946603.77% in 2024 and a maximum decrease of 14277.11% in 2024.
- Over the past 5 years, Zevra Therapeutics' Shares Issued (Quarter) stood at -$2.3 million in 2021, then skyrocketed by 104.6% to $108000.0 in 2022, then surged by 5350.93% to $5.9 million in 2023, then surged by 976.44% to $63.4 million in 2024, then plummeted by 95.25% to $3.0 million in 2025.
- Its Shares Issued was $3.0 million in Q3 2025, compared to $968000.0 in Q2 2025 and $2.0 million in Q1 2025.